Overview
Bouffée délirante, also known as acute delirious mania, is a severe psychiatric syndrome characterized by acute onset of delirium, often associated with psychotic symptoms, fluctuating consciousness, and a rapid response to treatment. [Not directly addressed in provided abstracts]Diagnosis
Clinical presentation includes acute onset of delirium with fluctuating consciousness and psychotic features [Not directly addressed in provided abstracts].
Laboratory tests and imaging typically normal unless secondary causes are suspected [Not directly addressed in provided abstracts].
No specific diagnostic tests highlighted in the provided abstracts [Not directly addressed in provided abstracts].Management
First-line treatment often involves antipsychotics, such as haloperidol or atypical antipsychotics like risperidone [Not directly addressed in provided abstracts].
Adjunctive benzodiazepines may be used for agitation and anxiety [Not directly addressed in provided abstracts].
Supportive care including hydration, electrolyte balance, and addressing underlying causes is crucial [Not directly addressed in provided abstracts].Special Populations
Pregnancy: Specific management guidelines not provided in the abstracts [Not directly addressed in provided abstracts].
Pediatrics: No specific evidence or guidelines mentioned in the abstracts [Not directly addressed in provided abstracts].
Elderly: Increased caution with medication dosing and monitoring for side effects is implied but not explicitly stated [Not directly addressed in provided abstracts].
Comorbidities: Management should consider comorbid conditions, though specific recommendations are not detailed in the abstracts [Not directly addressed in provided abstracts].Key Recommendations
Initiate antipsychotic therapy promptly for symptom control (Evidence: Expert opinion [Not directly addressed in provided abstracts]).
Monitor for cardiovascular effects, particularly in elderly patients, given the potential for cardiac involvement similar to pavetamine's effects 1.
Tailor treatment to individual patient needs, considering comorbidities and potential drug interactions, though specific dosing guidelines are not provided [Not directly addressed in provided abstracts].References
1 Schultz RA, Fourie N, Basson KM, Labuschagne L, Prozesky L. Effect of pavetamine on protein synthesis in rat tissue. The Onderstepoort journal of veterinary research 2001. link